93 related articles for article (PubMed ID: 3369120)
21. Characterisation of the sympathetic nervous system of Asian (Elephas maximus) and African (Loxodonta africana) elephants based on urinary catecholamine analyses.
Dehnhard M
Gen Comp Endocrinol; 2007 May; 151(3):274-84. PubMed ID: 17336981
[TBL] [Abstract][Full Text] [Related]
22. [Clinical picture and features of the dynamics of vegetative crises in patients with neurotic disorders].
Pankova OF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1681-6. PubMed ID: 6675368
[TBL] [Abstract][Full Text] [Related]
23. [Clinico-neurohumoral interrelationships in neuroses].
Diukova GM; Bol'shakova TD; Rodshtat IV; Dibobes GK; Tiabenkova VF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):227-31. PubMed ID: 757984
[TBL] [Abstract][Full Text] [Related]
24. [Sympatho-adrenergic function in congestive heart failure. I. Changes in urinary excretion of adrenaline and noradrenaline].
Descovich GC; Bernardi P; Lenzi S; Rimondi S; Brunelli A; Casarini P; Bargossi A; Ceredi C; Montaguti U; Dejana E
Boll Soc Ital Cardiol; 1972; 17(10):886-902. PubMed ID: 4681411
[No Abstract] [Full Text] [Related]
25. [Excretion of corticosteroids and catecholamines in cancer of the rectum and stomach].
Tarutinov VI; Maevskaia LP; El'chits TV
Vopr Onkol; 1977; 23(5):45-50. PubMed ID: 560758
[TBL] [Abstract][Full Text] [Related]
26. Urinary catecholamines and the diagnosis of phaeochromocytoma in Auckland.
McNeil AR; Woollard GA
N Z Med J; 1997 Sep; 110(1051):331-3. PubMed ID: 9323371
[TBL] [Abstract][Full Text] [Related]
27. [Excretion of catecholamines and DOPA in lipid metabolism disorders].
Frolova IA; Oleneva VA; Paramonova EG; Volkova IS; Sirota II
Vopr Med Khim; 1977; (6):797-803. PubMed ID: 595486
[TBL] [Abstract][Full Text] [Related]
28. [Activity of the sympatho-adrenal system in patients with hysterical psychopathy and psychasthenia].
Trunova MM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(11):1662-6. PubMed ID: 726762
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M
Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691
[TBL] [Abstract][Full Text] [Related]
30. [Excretion of catecholamines and lipid composition of blood in patients with chronic pancreatitis].
Frolova IA; Tsagikian TA; Borisova LI; Gordeeva VA; Sirota II
Vopr Med Khim; 1983; 29(2):127-30. PubMed ID: 6407200
[TBL] [Abstract][Full Text] [Related]
31. [Clinico-dynamic features of obsessive-phobic neurosis with onset during involution and old age].
Sergeev II
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(11):1681-6. PubMed ID: 726765
[TBL] [Abstract][Full Text] [Related]
32. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
[TBL] [Abstract][Full Text] [Related]
33. Decreased nocturnal catecholamine excretion: parameter for an overtraining syndrome in athletes?
Lehmann M; Schnee W; Scheu R; Stockhausen W; Bachl N
Int J Sports Med; 1992 Apr; 13(3):236-42. PubMed ID: 1601559
[TBL] [Abstract][Full Text] [Related]
34. [Autonomic dysfunction in patients with temporal lobe epilepsy].
Gleĭzer MA; Karlov VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(6):11-5. PubMed ID: 3055770
[TBL] [Abstract][Full Text] [Related]
35. [Activity of the sympathetico-adrenal system in humans during modeling of weightlessness].
Vasil'ev VN; Lakota NG; Chekanova SL; Gudoshnikova LV
Kosm Biol Aviakosm Med; 1989; 23(2):34-40. PubMed ID: 2716267
[TBL] [Abstract][Full Text] [Related]
36. No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure.
Mihai R; Wong NA; Luckett M; Sheffield E; Farndon JR
Br J Surg; 1998 Dec; 85(12):1681-5. PubMed ID: 9876074
[TBL] [Abstract][Full Text] [Related]
37. Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment.
Nigmatullina RR; Kirillova VV; Jourjikiya RK; Mukhamedyarov MA; Kudrin VS; Klodt PM; Palotás A
Cardiology; 2009; 113(4):277-86. PubMed ID: 19270454
[TBL] [Abstract][Full Text] [Related]
38. Relationship between overnight neuroendocrine activity and morning haemostasis in working men.
von Känel R; Kudielka BM; Abd-el-Razik A; Gander ML; Frey K; Fischer JE
Clin Sci (Lond); 2004 Jul; 107(1):89-95. PubMed ID: 15027894
[TBL] [Abstract][Full Text] [Related]
39. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
